Pyridium 100 MG Oral Tablet
Generic Name: PHENAZOPYRIDINE
Brand Name: Pyridium
- Substance Name(s):
- PHENAZOPYRIDINE HYDROCHLORIDE
OVERDOSAGE
Exceeding the recommended dose in patients with good renal function or administering the usual dose to patients with impaired renal function (common in elderly patients) may lead to increased serum levels and toxic reactions.
Methemoglobinemia generally follows a massive, acute overdose.
Methylene blue, 1 to 2 mg/kg/body weight intravenously or ascorbic acid 100 to 200 mg given orally should cause prompt reduction of the methemoglobinemia and disappearance of the cyanosis which is an aid in diagnosis.
Oxidative Heinz body hemolytic anemia may also occur, and “bite cells” (degmacytes) may be present in a chronic overdosage situation.
Red blood cell G-6-PD deficiency may predispose to hemolysis.
Renal and hepatic impairment and occasional failure, usually due to hypersensitivity, may also occur.
DESCRIPTION
Pyridium ® (Phenazopyridine Hydrochloride) is light or dark red to dark violet, odorless, slightly bitter, crystalline powder.
It has a specific local analgesic effect in the urinary tract, promptly relieving burning and pain.
It has the following structural formula: C 11 H 11 N 5 •HCl M.W.
249.70 Pyridium (Phenazopyridine HCl Tablets, USP) contains the following inactive ingredients: carnauba wax, croscarmellose sodium, hypromellose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, povidone and pregelatinized starch.
Structural Formula
HOW SUPPLIED
100 mg Tablets: Supplied in bottles of 100 (NDC 60846-501-01) counts.
Appearance: Deep brown to maroon colored, round, film coated tablets debossed “PY” above “1” on one side and plain on the other.
200 mg Tablets: Supplied in bottles of 100 (NDC 60846-502-01) counts.
Appearance: Deep brown to maroon colored, round, film coated tablets debossed “PY” above “2” on one side and plain on the other.
DISPENSE contents with a child-resistant closure (as required) and in a tight container as defined in the USP.
STORE at 20° to 25°C (68° to 77°F); excursions permitted between 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].
Manufactured for: Amneal Specialty, a division of Amneal Pharmaceuticals LLC Bridgewater, NJ 08807 Rev.
03-2019-00
INDICATIONS AND USAGE
Pyridium is indicated for the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters.
The use of Phenazopyridine HCl for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions.
Because it provides only symptomatic relief, prompt appropriate treatment of the cause of pain must be instituted and Phenazopyridine HCl should be discontinued when symptoms are controlled.
The analgesic action may reduce or eliminate the need for systemic analgesics or narcotics.
It is, however, compatible with antibacterial therapy and can help to relieve pain and discomfort during the interval before antibacterial therapy controls the infection.
Treatment of a urinary tract infection with Phenazopyridine HCl should not exceed two days because there is a lack of evidence that the combined administration of Phenazopyridine HCl and an antibacterial provides greater benefit than administration of the antibacterial alone after two days.
(See DOSAGE AND ADMINISTRATION section.)
NUSRING MOTHERS
Nursing mothers: No information is available on the appearance of Phenazopyridine HCl, or its metabolites in human milk.
DOSAGE AND ADMINISTRATION
100 mg Tablets: Average adult dosage is two tablets 3 times a day after meals.
200 mg Tablets: Average adult dosage is one tablet 3 times a day after meals.
When used concomitantly with an antibacterial agent for the treatment of a urinary tract infection, the administration of Phenazopyridine HCl should not exceed 2 days.